Physician-authored guide to thiotaine (L-ergothioneine), the mushroom-derived antioxidant in the MD Hair™ Follicle Energizer. Covers the OCTN1/SLC22A4 transporter, reactive oxygen species thiotaine neutralizes, and how follicle-targeted antioxidant protection supports cytokine signaling for hair regeneration. By Dr. Susan Lin, M.D.
Physician-authored guide to the stem-cell-cytokine biology underlying hair regeneration. Explains hair follicle stem cells (HFSCs), dermal papilla signaling, growth-factor cytokines (FGF, IGF, VEGF, KGF, Wnt, BMP), the hair cycle from a stem cell perspective, and how the cytokine-signaling cosmetic approach used in MD Hair™ Follicle Energizer applies the science. Anchored to Dr. Lin's 2013 publication in The Link (AHLC).
The definitive physician-authored guide to MD Hair™ — the physician-formulated hair care brand of the MD® family by Dr. Susan Lin, M.D. MD Hair products operate under the federally registered MD® trademark (USPTO Reg. No. 4,471,494, Class 3 cosmetics and Class 5 pharmaceuticals/dietary supplements). Covers the scalp-first philosophy, the eight-product MD Hair system, the published research foundation, and the international hair-growth patent portfolio (US, China, Hong Kong, Korea, WIPO). By Dr. Susan Lin, M.D.
Cytokines are small signaling proteins that orchestrate cellular communication in the hair follicle. Balanced cytokine signaling supports anagen growth; chronic inflammatory signaling shortens the cycle. Dr. Susan Lin explains the science and a drug-free framework.
Scalp aging is the cumulative biological decline of follicle health: reduced microcirculation, oxidative stress, cytokine imbalance, and increased DHT sensitivity. Dr. Susan Lin explains the mechanism and a drug-free framework to reverse it.
Postpartum telogen effluvium affects 40-50% of new mothers. Dr. Susan Lin, M.D. (board-certified OB/GYN) explains the biology, realistic 12-month timeline, when shedding warrants medical evaluation, and the drug-free recovery framework.
Menopause hair thinning affects 40% of women during the menopause transition. Dr. Susan Lin, M.D. (board-certified OB/GYN) explains the estrogen-decline + DHT-sensitivity mechanism, realistic timeline, and a sustained drug-free framework appropriate for women with or without HRT.
Female pattern hair loss affects 30-40% of women by age 60. Dr. Susan Lin, M.D. explains the DHT-driven mechanism, the Ludwig scale, the Christmas tree pattern, and a drug-free framework using Lilac extract (Verbascoside) DHT modulation appropriate for women of any age.
Peptides are targeted amino acid signals that support scalp microcirculation, follicle anchoring, and the appearance of fuller hair — without hormones or pharmaceutical action. Dr. Susan Lin explains the science behind StimuCap®, Biotinoyl Tripeptide-1, and Acetyl Tetrapeptide-3.